(December 08 04:26) Forbes.com
Non-psychedelic version of ibogaine developed by Delix Therapeutics to be studied by the National Institute on Drug Abuse as a medicine for opioid, methamphetamine, and cocaine substance use disorders.
You can find the original article
here